Luis Gerardo Rodríguez‐Lobato

Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study

Aina Oliver‐Caldés, Verónica González‐Calle, Valentín Cabañas et al. · The Lancet Oncology · 2023 · 76 citations · Full text

Hematological Malignancy, Medicine, Immunology +7

Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression

Carlos Fernández de Larrea, Ignacio Isola, Arturo Pereira et al. · Leukemia · 2018 · 63 citations

Hematological Malignancy, Medicine, Hematology +9

European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma

Benedetto Bruno, Ralph Wäsch, Monika Engelhardt et al. · Haematologica · 2021 · 52 citations · Full text

Relapsed/refractory Patients, Immunology, T Cells +16

Nectin-2 Expression on Malignant Plasma Cells Is Associated with Better Response to TIGIT Blockade in Multiple Myeloma

Ester Lozano, Mari-Pau Mena, Tania Díaz et al. · Clinical Cancer Research · 2020 · 48 citations · Full text

First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma

Aina Oliver‐Caldés, Raquel Jiménez, Marta Español‐Rego et al. · Journal for ImmunoTherapy of Cancer · 2021 · 45 citations · Full text